drugset
drugset / Trial / NCT01367587

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone

NCT01367587 ↗

Phase 2 Completed 12 enrolled Bausch Health Americas, Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study evaluates the safety of multiple doses of IV MNTX in normal healthy adults.

Timeline

Start
2002-04
Primary completion
2002-07
Completion
2002-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified — Intravenous

Indications

No indication recorded.